MAIURI, Luigi
 Distribuzione geografica
Continente #
EU - Europa 2.021
NA - Nord America 1.913
AS - Asia 411
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 7
OC - Oceania 1
Totale 4.360
Nazione #
US - Stati Uniti d'America 1.908
IE - Irlanda 853
DE - Germania 383
UA - Ucraina 352
SE - Svezia 272
CN - Cina 232
SG - Singapore 114
IT - Italia 72
FI - Finlandia 60
HK - Hong Kong 36
GB - Regno Unito 14
IR - Iran 10
VN - Vietnam 10
EU - Europa 7
BR - Brasile 6
FR - Francia 6
IN - India 6
CA - Canada 5
IL - Israele 2
NL - Olanda 2
SI - Slovenia 2
AL - Albania 1
AR - Argentina 1
BE - Belgio 1
DK - Danimarca 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 4.360
Città #
Dublin 853
Jacksonville 703
Dearborn 345
Wilmington 189
Lawrence 117
Princeton 117
Beijing 97
Singapore 65
Ashburn 45
Hong Kong 36
Andover 30
Hefei 28
Piemonte 26
Ann Arbor 25
San Mateo 19
Nanjing 18
Chandler 15
Norwalk 15
Houston 12
Kunming 12
Helsinki 11
Milan 11
Dong Ket 10
Fairfield 9
Jinan 9
Philadelphia 8
Ardabil 7
Shanghai 7
Woodbridge 7
Florianópolis 6
Nanchang 6
San Giuliano Milanese 6
Bremen 4
Chongqing 4
Fuzhou 4
Guangzhou 4
Hangzhou 4
Monmouth Junction 4
San Diego 4
Seattle 4
Toronto 4
Buffalo 3
Cambridge 3
Shenyang 3
Wuhan 3
Zhengzhou 3
Zionsville 3
Augusta 2
Baotou 2
Castiglione Olona 2
Harbin 2
Hebei 2
Leawood 2
Ljubljana 2
Naples 2
Ningbo 2
Santa Clara 2
Santhià 2
Simi Valley 2
Torino 2
Xian 2
Zanjan 2
Albizzate 1
Auckland 1
Boardman 1
Borgo Vercelli 1
Brussels 1
Buenos Aires 1
Changchun 1
Changsha 1
Chengdu 1
Düsseldorf 1
Huzhou 1
Kyiv 1
London 1
Monte Di Procida 1
Mountain View 1
Mumbai 1
Munich 1
New York 1
Ottawa 1
Quzhou 1
Rome 1
San Jose 1
Shaoxing 1
Taizhou 1
Tirana 1
Turin 1
Wenzhou 1
Yinchuan 1
Totale 2.976
Nome #
Administration of vitamin D and high dose of omega 3 to sustain remission of type 1 diabetes 64
Fetuin B Links Vitamin D deficiency and Pediatric Obesity: Direct Negative Regulation by Vitamin D. 64
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 64
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 60
Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy 59
Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps 58
Congenital Hypopigmentary Disorders with Multiorgan Impairment: A Case Report and an Overview on Gray Hair Syndromes 56
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 55
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation 55
Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. 54
Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood 54
Virtual unfolding of light sheet fluorescence microscopy dataset for quantitative analysis of the mouse intestine 53
A omega-secalin contained decamer shows a celiac disease prevention activity 52
TG2 regulates the heat-shock response by the post-translational modification of HSF1 51
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 50
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition 49
Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator 47
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease 47
Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis 46
The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways 46
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 46
Strategies for the etiological therapy of cystic fibrosis 46
Celiac disease: In vitro and in vivo safety and palatability of wheat-free sorghum food products. 45
A search for the holy grail: non-toxic gluten for celiac patients 45
Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect 45
Cellular basis of adult-type hypolactasia. 45
Crypt epithelial cells express the 4F2 antigen in untreated coeliac mucosa. 44
Celiac Disease: a common food intolerance on an immunological basis 44
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR 44
Cellular basis of adult-type hypolactasia 43
Cranial metastases of neuroblastoma of unusual size 43
Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa 43
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator 42
Analysis of lactase processing in rabbit. 42
Cerebral artery aneurysms in childhood 42
Towards a rational combination therapy of cystic fibrosis: How cystamine restores the stability of mutant CFTR 42
Cystic fibrosis: a disorder with defective autophagy 41
Celiac disease: a model autoimmune disease with gene therapy applications 41
A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance 41
Unexpected role of surface transglutaminase type II in celiac disease 41
Autophagy delays progression of the two most frequent human monogenetic lethal diseases: cystic fibrosis and Wilson disease 41
Design and characterization of a chitosan physical gel promoting wound healing in mice 40
Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation 40
The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation 40
FOXO1 content is reduced in cystic fibrosis and increases with IGF-I treatment 40
Metabolic interactions between cysteamine and epigallocatechin gallate 40
Evaluation of autophagy inducers in epithelial cells carrying the Δf508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR 40
Nebulized Hyaluronan Ameliorates lung inflammation in cystic fibrosis mice 40
Semilobar holoprosencephaly: embryologic, CSF dynamics and radiological considerations. 40
Reply to 'F508del-CFTR is not corrected by thymosin α1' 40
Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure (Journal of Clinical Investigation (2010) 120, 1 (203-213) (DOI:10.1172/JCI37672)) 40
Blockage of T-cell costimulation inhibits T-cell action in celiac disease. 39
Mosaic differentiation of human villus enterocytes: patchy expression of blood group A antigen in A nonsecretors. 39
Vertebral osteoid osteoma, rare cause of nerve root compression and scoliosis in childhood 38
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. 38
Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia. 38
Cellular basis of adult-type hypolactasia 38
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator 38
Patchy expression of lactase protein in adult rabbit and rat intestine 37
Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice 37
Mosaic regulation of lactase in human adult-type hypolactasia 37
SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation 37
In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. 37
Introduction to oxidative stress and antioxidant therapy 36
Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. 36
Early tissue transglutaminase-mediated response underlies K562(S)-cell gliadin-dependent agglutination 36
IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut 36
Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model 35
Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: An in vivo/in vitro pilot study 35
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. 35
Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides. 35
Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides. 34
In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA 34
Lactase activity of the enterocytes of human proximal jejunum with adult-type hypolactasia 34
Lactase persistence versus decline in human adults: multifactorial events are involved in down-regulation after weaning. 34
Sturge-Weber disease without facial nevus 34
Gliadin as a stimulator of innate responses in celiac disease 34
Interleukin 15 mediates epithelial changes in celiac disease. 34
Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance 34
Morphological method for the diagnosis of human adult type hypolactasia. 33
FAS engagement drives apoptosis of enterocytes of coeliac patients. 33
In vitro organ culture system 33
Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans. 33
The lipid A of Burkholderia multivorans C1576 smooth-type lipopolysaccharide and its pro-inflammatory activity in a cystic fibrosis airways model. 33
DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? 32
L-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. 32
Immunologic and intestinal permeability tests as predictors of relapse during gluten challenge in childhood coeliac disease. 32
Malignant extradural spinal cord compression in childhood: diagnostic, surgical, and prognostic considerations with respect to 6 cases 32
In vitro gluten challenge 32
High incidence of spontaneous autoimmune thyroiditis in immunocompetent self-reactive human T cell receptor transgenic mice 32
Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. 31
Mucosal cell-mediated immunity in Coeliac Disease 31
Gluten-sensitive disease with mild enteropathy 31
Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. 31
Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro 31
Plexiform neurofibroma of the occipital scalp 30
Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa. 30
Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. 30
In vitro biosynthesis of lactase in preweaning and adult rabbit. 30
Diagnostic morphological methods: Use of immunomorphological and enzymo-histochemical methods for a single disease entity 29
Totale 4.060
Categoria #
all - tutte 29.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.060 0 0 0 0 206 210 290 57 136 24 137 0
2020/2021732 119 1 117 0 123 3 118 1 118 2 119 11
2021/2022477 3 19 18 61 17 0 30 17 54 10 92 156
2022/20231.235 121 43 66 8 6 59 37 54 787 4 30 20
2023/2024313 30 29 18 5 93 1 35 11 2 4 3 82
2024/202563 10 6 17 14 16 0 0 0 0 0 0 0
Totale 4.520